First Header Logo Second Header Logo

Connection

David Kline to Sodium Channel Blockers

This is a "connection" page, showing publications David Kline has written about Sodium Channel Blockers.
Connection Strength

0.165
  1. Lorusso S, Kline D, Bartlett A, Freimer M, Agriesti J, Hawash AA, Rich MM, Kissel JT, David Arnold W. Open-label trial of ranolazine for the treatment of paramyotonia congenita. Muscle Nerve. 2019 02; 59(2):240-243.
    View in: PubMed
    Score: 0.165
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.